Obliterative bronchiolitis

Clinics in Chest Medicine

Volumn 18, Issue 2, 1997, Pages 319-338

  Kelly, K ^a   Hertz, M I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CYCLOSPORIN A; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; METHOTREXATE; METHOXSALEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

AIRWAY OBSTRUCTION; ALLOIMMUNITY; BRONCHIOLITIS; BRONCHOSCOPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; EFFECTOR CELL; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; SPIROMETRY; THORAX RADIOGRAPHY;

EID: 0030912712     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70382-8     Document Type: Article

References (156)

1. E.C. Abernathy R.J. Hruban W.A. Baumgartner The two forms of bronchiolitis obliterans in heart–lung transplant recipients Hum Pathol 22 1991 1102 1110
2. D.H. Adams A.D. Cochrane A. Khaghani Retransplantation in heart–lung recipients with obliterative bronchiolitis J Thorac Cardiovasc Surg 107 1994 450 459
3. Y. Akselband M.W. Harding P.A. Nelson Rapamycin inhibits spontaneous and fibroblast growth factor β-stimulated proliferation of endothelial cells and fibroblasts Trans Proc 23 1991 2833 2836
4. G. Al-Dossari J. Jessurun Morton Bolman R. III Pathogenesis of obliterative bronchiolitis Transplantation 59 1995 143 145
5. W.D. Allen C.M. Burke C.G.A. McGregor Steroid-responsive bronchiolitis after human heart–lung transplantation J Thorac Cardiovasc Surg 92 1986 449 451
6. G. Andreu A. Achkar J.P. Couetil Extracorporeal photochemotherapy treatment for acute lung rejection episode Transplantation 14 1995 793 796
7. E. Arbustini P. Morbini M. Grasso Human cytomegalovirus early infection, acute rejection, and major histocompatibility class II expression in transplanted lung. Molecular, immunocytochemical, and histopathologic investigations Transplantation 61 1996 418 427
8. K. Bando I.L. Paradis S. Similo Obliterative bronchiolitis after lung and heart–lung transplantation. An analysis of risk factors and management J Thorac Cardiovasc Surg 110 1995 4 14
9. F.S. Becker F.J. Martinez L.A. Brunsting Limitations of spirometry in detecting rejection after single-lung transplantation Am J Respir Crit Care Med 150 1994 159 166
10. C.M. Burke J.C. Baldwin A.J. Morris Twenty-eight cases of human heart–lung transplantation Lancet 1 1986 517
11. C.M. Burke A.R. Glanville J.A. Macoviak The spectrum of cytomegalovirus infection following human heart–lung transplantation J Heart Transplant 5 1986 267 272
12. C.M. Burke J. Theodore K.D. Dawkins Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart–lung transplantation Chest 86 1984 824 829
13. B. Cahill M.K. O'Rourke K.A. Strasburg Methotrexate for lung transplant recipients with steroid resistant acute rejection J Heart Lung Transplant 15 1996 1130 1137
14. T. Carr Bolman R.M. III E. Perry Photopheresis for chronic rejection of lung transplant in a small pediatric patient J Clin Apheresis 10 1995 1995
15. D. Chamberlain J. Maurer C. Chaparro Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation J Heart Lung Transplant 13 1994 963 971
16. C. Chaparro J.R. Maurer D. Chamberlain Causes of death in lung transplant recipients J Heart Lung Transplant 13 1994 758 766
17. C. Clelland T. Higgenbottam B. Otulana Histologic prognostic indicators for the lung allografts of heart–lung transplants J Heart Transplant 9 1990 177 186
18. J.D. Cooper Toronto Lung Transplant Group Unilateral lung transplantation for pulmonary fibrosis N Engl J Med 314 1986 1140 1146
19. J.D. Cooper M. Billingham T. Egan A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation J Heart Lung Transplant 12 1993 713 716
20. J.D. Cooper G.A. Patterson E.P. Trulock Results of single and bilateral lung transplantation in 131 consecutive recipients. Washington University Lung Transplant Group J Thorac Cardiovasc Surg 107 1994 460 470
21. M.R. Costanzo-Nordin B.B. Grusk M.A. Silver Reversal of recalcitrant cardia allograft rejection with methotrexate Circulation 78 1988 11147 11157
22. M.R. Costanzo-Nordin E.A. Hubbell E.J. O'Sullivan Successful treatment of heart transplant rejection with photopheresis Transplantation 53 1992 808 815
23. R.C. Daly C.G. McGregor Routine immediate direct bronchial artery revascularization for single-lung transplantation Ann Thorac Surg 57 1994 1446 1452
24. J.H. Dauber I.L. Paradis J.S. Dummer Infectious complications in pulmonary allograft recipients Clin Chest Med 11 1990 291 308
25. A.J. Duncan J.S. Dummer I.L. Paradis Cytomegalovirus infection and survival in lung transplant recipients J Heart Lung Transplant 10 1991 638 644
26. S.R. Duncan I.L. Paradis S.A. Yousem Sequelae of cytomegalovirus pulmonary infection in lung allograft recipients Am Rev Respir Dis 146 1992 1419 1425
27. M. Dusmet J. Maurer T. Winton Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients J Heart Lung Transplant 15 1996 948 954
28. R.D. Ensley M.R. Bristow S.L. Olsen The use of mycophenoate mofetil (RS-61443) in human heart transplant recipients Transplantation 56 1993 75 82
29. N.A. Ettinger T.C. Bailey E.P. Trulock Cytomegalovirus pneumonitis: Impact following isolated lung transplantation Am Rev Respir Dis 147 1993 1017 1023
30. M. Fattal-German I. Frachon J. Cerrina Particular phenotypic profile of blood lymphocytes during obliterative bronchiolitis syndrome following lung transplantation Transplant Immunol 2 1994 243 251
31. F. Fend C. Prior R. Margreiter Cytomegalovirus pneumonitis in heart–lung transplant recipients Hum Pathol 21 1990 918 926
32. S. Finkelstein M.I. Hertz M. Snyder Reliability of home spirometry data in lung transplantation Proc IEEE/EMBS 15 1993 659 660
33. S. Finkelstein B. Lindgren M. Prasad Reliability and validity of spirometry measurements in a paperless home monitoring diary program for lung transplantation Heart Lung 22 1993 523 533
34. R.S. Fujinami J.A. Nelson L. Walker Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR β chain: A means for graft rejection and immunosuppression J Virol 62 1988 100 105
35. J.J. Fung A. Zeevi C. Kaufman Interactions between bronchoalveolar lymphocytes and macrophages in heart–lung transplant recipients Hum Immunol 14 1985 287 294
36. S.Z. Gao J.S. Schroeder E.L. Alderman Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient Circulation 76 suppl 5 1987 56
37. L.J. Geist M.M. Monick M.F. Stinski Cytomegalovirus immediate early genes prevent the inhibitory effect of cyclosporine A on interleukin-2 gene expression J Clin Invest 90 1992 2136 2140
38. A.R. Glanville J.C. Baldwin C.M. Burke Obliterative bronchiolitis after heart–lung transplantation: Apparent arrest by augmented immunosuppression Ann Intern Med 107 1987 300 304
39. C.R. Gregory P. Huie M.E. Billingham Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor and cytokine response in injured vessels Transplantation 55 1993 1409 1418
40. B.P. Griffith R.L. Hardesty J.M. Armitage A decade of lung transplantation Ann Surg 218 1993 310 320
41. C.R. Gross K. Savik R.M. Bolman III Long-term health status and quality-of-life outcomes of lung transplant recipients Chest 108 1995 1587 1593
42. S.A. Gruber The case for local immunosuppression Transplantation 54 1992 1 11
43. R.A. Guilinger I.L. Paradis J.H. Dauber The importance of bronchoscopy with transbronchial biopsy and broncho-alveolar lavage in the management of lung transplant recipients Am J Respir Crit Care Med 152 1995 2037 2043
44. R.A. Halverson Jr R.P. DuCret C.C. Kuni Obliterative bronchiolitis following lung transplantation diagnostic utility of aerosol ventilation lung scanning and high resolution CT Clin Nuclear Med 16 1990 256 258
45. A. Harjula J. Baldwin A. Glanville Human leukocyte-antigen compatibility in heart–lung transplantation J Heart Lung Transplant 6 1987 162 166
46. S. Hasegawa D.M. Ockner J.H. Ritter Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection Arch Pathol Lab Med 119 1995 432 439
47. B. Hausen A. Dwenger B. Gohrbandt Early biochemical indicators of the obliterative bronchiolitis syndrome in lung transplantation J Heart Lung Transplant 13 1994 980 989
48. M. Hemler M. Elices C. Parker Structure of the integrin VLA-4 and its cell–cell matrix adhesion functions Immunol Rev 114 1990 45 65
49. M.I. Hertz C.A. Henke R.E. Nakhleh Obliterative bronchiolitis after lung transplantation: A fibroproliferative disorder associated with platelet-derived growth factor Proc Natl Acad Sci USA 89 1992 10385 10389
50. M.I. Hertz J. Jessurun M.B. King Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways Am J Pathol 142 1993 1945 1951
51. T. Higenbottam S. Stewart A. Penketh Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients Transplantation 46 1988 532 539
52. K. Hines A. Kulkarni J.B. McCarthy Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor β1 knockout mice Proc Natl Acad Science USA 91 1994 5187 5191
53. V.A. Holland P.T. Cagle N.T. Windsor Lymphocyte subset populations in bronchiolitis obliterans after heart–lung transplantation Transplantation 50 1990 955 959
54. J. Horina R. Mullegger S. Ham Photopheresis for renal allograft rejection Lancet 346 1995 61
55. A.T. Iacono R.J. Keenan S.R. Duncan Aerosolized cyclosporine in lung recipients with refractory chronic rejection Am J Respir Crit Care Med 153 1996 1451 1455
56. L. Ibrahim M. Dominguez M. Yacoub Primary human adult lung epithelial cells in vitro: Response to interferon and cytomegalovirus Immunology 79 1993 119 124
57. T. Ikonen L. Kiv A.L.J. Harjula Value of high-resolution computed tomography in routine evaluation of lung transplantation recipients during development of bronchiolitis obliterans syndrome J Heart Lung Transplant 15 1996 587 595
58. Y. Iwaki Y. Yoshida B. Griffith The HLA-matching effect in lung transplantation Transplantation 56 1993 1528 1529
59. S.C. Jordan M. Alberto D. Ross Serum interleukin-2 levels in lung transplant recipients: Correlation with findings on transbronchial biopsy J Heart Lung Transplant 11 1992 1001 1004
60. S. Joyce J.M. Mathew M.W. Flye A polymorphic human kidney-specific non-MHC alloantigen: Its possible role in tissue-specific allograft immunity Transplantation 53 1992 1119 1127
61. B.D. Kahan S. Gibbons N. Tejpal Synergistic effect of the rapamycin/cyclosporine combination: Median effect analysis of in vitro performances by human T lymphocytes in PHA, CD3 and MLR proliferative and cytotoxicity assays Transplant Proc 23 1991 1090 1091
62. A.K. Kamada S.J. Szefler R.J. Martin Issues in the use of inhaled glucocorticoids Am J Respir Crit Care Med 153 1996 1739 1748
63. R.J. Keenan H. Konishi A. Kawai Clinical trial of tacrolimus versus cyclosporine in lung transplantation Ann Thorac Surg 60 1995 580 585
64. C.A. Keller P.T. Cagle R.W. Brown Bronchiolitis obliterans in recipients of single, double and heart–lung transplantation Chest 107 1995 973 980
65. S. Kesten D. Chamberlain J. Maurer Yield of surveillance transbronchial biopsies performed beyond 2 years after lung transplantation J Heart Lung Transplant 15 1996 384 388
66. J.A. Kirby J.A. Reader J.R. Pepper Lung transplantation: Effect of cyclosporine A on the frequency of cytolytic lymphocytes recovered from blood and the bronchoalveolar space J Heart Transplant 5 1986 33 38
67. G.B. Klintman N.L. Ascher R.W. Busuttil RS-61443 for treatment-resistant human liver rejection Transplant Proc 25 1993 697
68. T. Kondo A.M. Marchevsky J. Prehn Evidence of complete tolerance in a model of rat lung allografts Transplantation 52 1991 928 930
69. M.R. Kramer C. Stoehr J.L. Whang The diagnosis of obliterative bronchiolitis after heart–lung and lung transplantation: Low yield of transbronchial lung biopsy J Heart Lung Transplant 12 1993 675 681
70. V.R. Kshettry T.J. Kroshus J. Burdine Does donor organ ischemia over 4 hours affect long-term survival after lung transplantation? J Heart Lung Transplant 15 1996 169 174
71. V. Kubit E. Sonmez-Alpan A. Zeevi Mixed allogeneic chimerism in lung allograft recipients Hum Pathol 25 1994 408 412
72. E.C. Lawrence V.A. Holland J.B. Young Dynamic changes in soluble interleukin-2 receptor levels after lung or heart–lung transplantation Am Rev Respir Dis 140 1989 789 796
73. S.M. Levine A. Anzueto J.I. Peters Medium-term functional results of single-lung transplantation for endstage obstructive lung disease Am J Respir Crit Care Med 150 1994 398 402
74. L. Lu D. McCaslin T.E. Starzl Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes Transplantation 60 1995 1539 1545
75. S.O. Marx T. Jayaraman L.O. Go Rapamycin-FKBP inhibits cell-cycle regulators of proliferation in vascular smooth muscle cells Circ Res 76 1995 412 417
76. Y. Matsumura A. Marchevsky X.J. Zuo Assessment of pathological changes associated with chronic allograft rejection and tolerance in two experimental models of rat lung transplantation Transplantation 59 1995 1507 1517
77. K. Mauck J.D. Hosenpud The bronchial epithelium: A potential allogeneic target for chronic rejection after lung transplantation J Heart Lung Transplant 15 1996 709 714
78. B.M. Meiser F. Kur H. Reichenspurner Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation Transplantation 57 1994 563 568
79. D.S. Milne A. Gascoigne J. Wilkes The immunohistopathology of obliterative bronchiolitis following lung transplantation Transplantation 54 1992 748 750
80. D.S. Milne A.D. Gascoigne J. Wilkes MHC class II and ICAM-1 expression and lymphocyte subsets in transbronchial biopsies from lung transplant recipients Transplantation 57 1994 1762 1766
81. D.S. Milne A.D. Gascoigne T. Ashcroft Organizing pneumonia following pulmonary transplantation and the development of obliterative bronchiolitis Transplantation 57 1994 1757 1762
82. S. Molossi M. Elices T. Arrhenius Blockade of very late antigen-4 integrin binding of fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy J Clin Invest 95 1995 2610
83. R.E. Morris Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides Transplant Rev 6 1992 39 87
84. S. Muthukkumar T.M. Ramesh S. Bondada Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells Transplantation 60 1995 264 270
85. R.J. Novick H.J. Schafers B. Andreassian Seventy-two pulmonary retransplantations for obliterative bronchiolitis: Predictors of survival Ann Thorac Surg 60 1995 111 116
86. B.A. Otulana T. Higenbottam L. Ferrari The use of home spirometry in detecting acute lung rejection and infection following heart–lung transplantation Chest 97 1990 353 357
87. I. Paradis S. Yousem B. Griffith Airway obstruction and bronchiolitis obliterans after lung transplantation Clin Chest Med 14 1993 751 763
88. G.M. Patterson S. Wilson J.L. Whang Physiologic definitions of obliterative bronchiolitis in heart–lung and double lung transplantation: A comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in 1 second J Heart Lung Transplant 15 1996 175 183
89. S.M. Pham R.J. Keenan A.S. Rao Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients Ann Thorac Surg 60 1995 1015 1020
90. A. Pomerance B. Madden M.M. Burke Transbronchial biopsy in heart and lung transplantation: Clinicopathologic correlations J Heart Lung Transplant 14 1995 761 773
91. H. Rabinowich A. Zeevi I.L. Paradis Proliferative responses of bronchoalveolar lavage lymphocytes from heart–lung transplant patients Transplantation 49 1990 115 121
92. H. Rabinowich A. Zeevi S.A. Yousem Alloreactivity of lung biopsy and bronchoalveolar lavage-derived lymphocytes from pulmonary transplant patients: Correlation with acute rejection and bronchiolitis obliterans Clin Transplant (Copenhagen) 4 1990 376 384
93. N.L. Reinsmoen M. Bolman K. Savik Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity J Heart Lung Transplant 13 1994 30 37
94. N.L. Reinsmoen R.M. Bolman K. Savik Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection? Transplantation 55 1993 1040 1044
95. N.L. Reinsmoen R.M. Bolman K. Savik Differentiation of class I and class II directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients Transplantation 53 1992 181 189
96. N.L. Reinsmoen A. Jackson C. McSherry Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients Transplantation 60 1995 1546 1554
97. B.A. Reitz J.L. Wallwork S.A. Hunt Successful therapy for patients with pulmonary vascular disease N Engl J Med 306 1982 557 564
98. A. Romaniuk J. Prop A.H. Petersen Expression of class II major histocompatibility complex antigens by bronchial epithelium in rat lung allografts Transplantation 44 1987 209 214
99. E.A. Rose M.L. Barr H. Xu Photochemotherapy in human heart transplant recipients at high risk for fatal rejection J Heart Lung Transplant 11 1992 746 750
100. D.J. Ross S.C. Jordan S.D. Nathan Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation: A plea for multicenter immunosuppressive trials Chest 109 1996 870 873
101. D.J. Ross A.Y. Yeh S.D. Nathan Differential soluble interleukin-2R levels in bilateral bronchoalveolar lavage after single lung transplantation J Heart Lung Transplant 13 1994 972 979
102. G.A. Rossi D. Sacco B. Balbi Human ciliated bronchial epithelial cells: Expression of the HLA-DR α gene, modulation of the HLA-DR antigens by γ interferon and antigen presenting function in the mixed leukocyte reaction Am J Respir Cell Mol Biol 3 1990 431 439
103. R.H. Rubin The indirect effects of cytomegalovirus infection on the outcome of organ transplantation [editorial] JAMA 261 1989 3607 3609
104. S.P. Salter M.M. Sather J.K. Kirklin Total lymphoid irradiation in the treatment of early or recurrent heart transplant rejection Int J Radiol Oncol Bio Phys 30 1995 83 88
105. G.E. Sarris J.A. Smith N.E. Shumway Long-term results of combined heart–lung transplantation: The Stanford experience J Heart Lung Transplant 13 1994 940 949
106. J. Scott T. Higenbottam L. Sharples Natural history of chronic rejection in heart–lung transplant recipient J Heart Transplant 9 1990 510 515
107. J.P. Scott G. Fradet R.L. Smyth Prospective study of transbronchial biopsies in the management of heart–lung and single lung transplant patients J Heart Lung Transplant 10 1991 626 637
108. J.P. Scott T.W. Higenbottam L. Sharples Risk factors for obliterative bronchiolitis in heart–lung transplant recipients Transplantation 51 1991 813 817
109. L.D. Sharples J.P. Scott C. Dennis Risk factors for survival following combined heart–lung transplantation Transplantation 57 1994 218 223
110. Y. Shi A. Frankel L.G. Radvanyi Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro Cancer Res 55 1995 1982 1988
111. Y. Shimizu S. Shaw Lymphocyte interaction with extracellular matrix FASEB J 5 1991 2292 2299
112. Y. Shimizu G. Van Seventer Horgan Costimulation of proliferative response of resting CD4 T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin J Immunol 145 1990 59 67
113. J.L. Skeens C.R. Fuhrman S.A. Yousem Bronchiolitis obliterans in heart–lung transplantation patients: Radiologic findings in 11 patients Am J Radiol 153 1989 253 256
114. B. Slovis J. Loyd L. King Jr Photopheresis for chronic rejection of lung allografts N Engl J Med 6 1995 962
115. G.I. Snell D.S. Esmore T.J. Williams Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation Chest 109 1996 874 878
116. G.I. Snell M. Rabinov A. Griffiths Pulmonary allograft ischemic time: An important predictor of survival after lung transplantation J Heart Lung Transplant 15 1996 160 168
117. H.W. Sollinger F.O. Belzer M.H. Deierhoi RS-61443 (mycophenolate mofetil): A multicenter study for refractory kidney transplant rejection Ann Surg 216 1992 513 519
118. G. Steinhoff A. Haverich Cell–cell and cell–matrix adhesion molecules in human heart and lung transplants Mol Cell Biochem 147 1995 21 27
119. S.M. Stepkowski S. Goto T. Ito Prolongation of heterotopic heart allograft survival by local delivery of continuous low-dose cyclosporine therapy Transplantation 47 1989 17 23
120. S. Sundaresan E.P. Trulock T. Mohanakumar Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation Ann Thorac Surg 90 1995 1341 1346
121. M. Takao T.W. Higenbottam T. Audley Effects of inhaled nebulized steroids (Budesonide) on acute and chronic lung function in heart–lung transplant patients Transplant Proc 27 1995 1284 1285
122. P.M. Taylor M. Rose M. Yacoub Expression of MHC antigens in normal human lungs and transplanted lungs with obliterative bronchiolitis Transplantation 48 1989 506 510
123. H.D. Tazelaar S.A. Yousem Pathologic findings in heart–lung transplantation Hum Pathol 208 1988 371 378
124. H.D. Tazelaar S.A. Yousem The pathology of combined heart–lung transplantation: An autopsy study Hum Pathol 19 1988 1403 1416
125. U. The S. Multicenter FK506 Liver Study Group: A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation N Engl J Med 331 1994 1110 1115
126. J. Theodore V.A. Starnes N.J. Lewiston Obliterative bronchiolitis Clin Chest Med 11 1990 309 321
127. N.L. Tilney W.D. Whitley J.R. Diamond Chronic rejection—an undefined conundrum Transplantation 52 1991 389 398
128. E.P. Trulock N.A. Ettinger E.M. Brunt The role of transbronchial lung biopsy in the treatment of lung transplant recipients: An analysis of 200 consecutive procedures Chest 102 1992 1049 1054
129. T. Uyama S. Sakiyama T. Fukumoto Graft-infiltrating cells in rat lung allograft with late airway damage Transplant Proc 27 1995 2118 2119
130. T. Uyama J.B. Winter G. Groen Replacement of dendritic dells in the airways of allografted rat lungs Trans Proc 23 1991 607 608
131. T. Uyama J.B. Winter G. Groen Late airway changes caused by chronic rejection in rat lung allografts Transplantation 54 1992 809 812
132. V.G. Valentine R.C. Robbins G.J. Berry Actuarial survival of heart–lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis J Heart Lung Trans 15 1996 371 383
133. V.G. Valentine R.C. Robbins J.H. Wehner Total lymphoid irradiation for refractory acute rejection in heart–lung and lung allografts Chest 109 1996 1136 1138
134. E. Von Willebrand E. Pettersson J. Ahonen CMV infection, class II antigen expression, and human kidney allograft rejection Transplantation 42 1986 364 367
135. S. Walh J. Allen K. Hines Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment J Clin Invest 94 1994 655 662
136. J. Wallwork Risk factors for chronic rejection in heart and lungs—why do hearts and lungs rot? Clin Transplant 8 1994 341 344
137. T. Wekerle W. Klepetko W. Wisser Lung retransplantation: Institutional report on a series of 20 patients J Heart Lung Transplant 15 1996 182 189
138. C.H. Wendt J.K. Fox M.I. Hertz Paramyxoviruses infection in lung transplant recipients J Heart Lung Transplant 14 1995 479 485
139. B.F. Whitehead C. Stoehr C.J. Wu Cytokine gene expression in human lung transplant recipients Transplantation 56 1993 956 961
140. M. Wieland V.L. Thiede R.G. Strauss Treatment of severe cardiac allograft rejection with extracorporeal photochemotherapy J Clin Apheresis 9 1994 171 175
141. R.H. Wiesner J. Ludwig B. Van Hoek Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure Hepatology 14 1991 721 729
142. J.B. Winter C. Clelland A. Gouw Distinct phenotypes of infiltrating cells during acute and chronic lung rejection in human heart–lung transplants Transplantation 59 1995 63 69
143. J.B. Winter A.S.H. Gouw M. Groen Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts Transplantation 57 1994 418 422
144. T.L. Winton J.D. Miller A. de Hoyos Graft function, airway healing, rejection, and survival in pulmonary transplantation are not affected by graft ischemia in excess of 5 hours Transplant Proc 25 1993 1649 1650
145. K. Yagyu P.J.C. van Breda Vriesman A.M. Duijvestijn Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts Transplant Proc 25 1993 1152 1154
146. Y. Yoshida Y. Iwaki S. Pham Benefits of posttransplantation monitoring of interleukin 6 in lung transplantation Ann Thorac Surg 55 1993 89 93
147. S.A. Yousem Lymphocytic bronchitis/bronchiolitis in lung allograft recipients Am J Surg Pathol 17 1993 491 496
148. S.A. Yousem C.M. Burke M.E. Billingham Pathologic pulmonary alterations in long-term human heart–lung transplantation Hum Pathol 16 1985 911 923
149. S.A. Yousem J.M. Curley J. Dauber HLA-class II antigen expression in human heart–lung allografts Transplantation 49 1990 991 995
150. S.A. Yousem J.A. Dauber R. Keenan Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 52 1991 306 309
151. S.A. Yousem S.R. Duncan N.P. Ohori Architectural remodeling of lung allografts in acute and chronic rejection Arch Pathol Lab Med 116 1992 1175 1180
152. S.A. Yousem I.L. Paradis J.A. Dauber Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heart–lung transplant recipients Transplantation 47 1989 893 895
153. S.A. Yousem I.L. Paradis J.A. Dauber Large airway inflammation in heart–lung transplant recipients—its significance and prognostic implications Transplantation 49 1990 654 656
154. S.A. Yousem I.L. Paradis B.P. Griffith Can transbronchial biopsy aid in the diagnosis of bronchiolitis obliterans in lung transplant recipients? Transplantation 57 1994 151 153
155. S.A. Yousem L. Ray I.L. Paradis Potential role of dendritic cells in bronchiolitis obliterans in heart–lung transplantation Ann Thorac Surg 49 1990 424 428
156. A. Zeevi J. Fung I. Paradis Lymphocytes of bronchoalveolar lavage from heart–lung transplant recipients Heart Transplant 4 1985 417 421